国际皮肤性病学杂志    2006 32 (2): 79-82   ISSN: 2096-5540  CN: 32-1880/R   动物模型与真菌病研究 佘晓东, 刘维达 1. 大连皮肤病医院 116021; 2. 中国医学科学院、中国协和医科大学皮肤病研究所 收稿日期 2005-11-02  修回日期 null  网络版发布日期 null 参考文献  [1] Treiber A,Pittermann W,Schuppe HC.Efficacy testing of antimycotic prophylactics in an animal model.Int J Hyg Environ Health,2001,204:239-243. [2] Svecova D.Experimental Trichophyton rubrum infection in animals.Epidemiol Mikrobiol Imunol,2000,49:75-79. [3] Majima T,Masui S,Uchida K,et al.A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs.Mycoses,2005,48:108-113. [4] Tatsumi Y,Yokoo M,Arika T,et al.In vitro antifungal activity of KP-103,a novel triazole derivative,and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.Antimicrob Agents Chemother,2001,45:1493-1499. [5] Tatsumi Y,Yokoo M,Arika T,et al.In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.Microbiol Immunol,2002,46:433-439. [6] Uchida K,Tanaka T,Yamaguchi H.Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model oftinea pedis.Microbiol Immunol,2003,47:143-146. [7] Fidel PL Jr,Barousse M,Espinosa T,et al.An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis ofvulvovaginal candidiasis.Infect Immun,2004,72:2939-2946. [8] De Bernardis F,Boccanera M,Adriani D,et al.Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.Infect Immun,2002,70:2725-2729. [9] Fidel PL Jr,Cutright JL,Tait L,et al.A murine model of Candida glabrata vaginitis.J Infect Dis,1996,173:425-431. [10] Brun S,Dalle F,Saulnier P,et al.Biological consequences of petite mutations in Candida glabrata.J Antimicrob Chemother,2005,56:307-314. [11] Spellberg B,Ibrahim AS,Edwards JE Jr,et al.Mice with disseminated candidiasis die of progressive sepsis.J Infect Dis,2005,192:336. [12] Netea MG,Sutmuller R,Hermann C,et al.Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.J Immunol,2004,172:3712-3718. [13] Green CB,Zhao X,Hoyer LL.Use of green fluorescent protein and reverse transcription-PCR to monitor Candida albicans agglutinin-like sequence gene expression in a murine model of disseminated candidiasis.Infect Immun,2005,73:1852-1855. [14] Huppert M,Sun SH,Gross AJ.Evaluation of an experimental animal model for testing antifungal substances.Antimicrob Agents Chemother,1972,1:367-372. [15] Fierer J,Walls L,Wright F,et al.Genes influencing resistance to Coccidioides immitis and the interleukin-10 response map to chromosomes 4 and 6 in mice.Infect Immun,1999,67:2916-2919. [16] Clemons KV,Stevens DA.Efficacies of sordarin derivatives GM193663,GM211676,and GM237354 in a murine model of systemic coccidioidomycosis.p6.Antimicrob Agents Chemother,2000,44:1874-1877. [17] Clemons KV,Stevens DA.Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.Antimicrob Agents Chemother,1991,35:1829-1833. [18] Sorensen KN,Sobel RA,Clemons KV,et al.Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.Antimicrob Agents Chemother,2000,44:3087-3091. [19] Deepe GS Jr,Gibbons RS.et al.Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.Infect Immun,2002,70:3759-3767. [20] Medeiros AI,Sa-Nunes A,Soares EG,et al.Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.Infect Immun,2004,72:1637-1644. [21] Durkin MM,Connolly PA,Karimi K,et al.Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var.capsulatum in experimentally infected mice.J Clin Microbiol,2004,42:4370-4373. [22] Waldorf AR,Ruderman N,Diamond RD.Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.J Clin Invest,1984,74:150-160. [23] Feldmesser M,Kress Y,NovikoffP,et al.Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.Infect Immun,2000,68:4225-4237. [24] Dixon DM,Duncan RA,Hurd NJ.Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp.from the largest U.S.epidemic of sporotrichosis.J Clin Microbiol,1992,30:951-954. [25] Carrillo-Munoz AJ,Giusiano G,Ezkurra PA,et al.Sertaconazole:updated review of a topical antifungal agent.Expert Rev Anti Infect Ther,2005,3:333-342. [26] Cardona-Castro N,Agudelo-Florez P.Development of a chronic chromoblastomycosis model in immunocompetent mice.Med Mycol,1999,37:81-83. 通讯作者: